EGFR and non-small cell lung carcinoma: In contrast to the EGFR mutation-positive disease, the ASR of EGFR mutation-negative NSCLC was lower in females than males: SIR 0.8 (95%CI 0.75–0.87); it was lower in Asians compared with New Zealand Europeans: SIR 0.68 (95%CI 0.6–0.78), but much higher in Māori: SIR 3.53 (95%CI 3.04–4.11) and higher in Pacifica: SIR 1.88 (95%CI 1.6–2.2).